Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs
NeutralFinancial Markets

European drugmakers are cautiously optimistic about avoiding the latest tariffs proposed by the Trump administration. This situation is significant as it could impact the pharmaceutical market and pricing strategies in Europe, potentially affecting drug availability and healthcare costs for consumers.
— Curated by the World Pulse Now AI Editorial System